Gastrointestinal Stromal Tumor Market Valuation Expected To Reach $1.82 Billion By 2029, Growing At A Rate Of 7%
Discover trends, market shifts, and competitive outlooks for the gastrointestinal stromal tumor industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#How Has The Gastrointestinal Stromal Tumor Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_
The market for gastrointestinal stromal tumors has seen significant growth in the past few years. It is projected to expand from $1.28 billion in 2024 up to $1.37 billion in 2025, at a compound annual growth rate (CAGR) of 7.2%. The notable growth during the historical period is due to factors like boosted awareness and early detection, the arrival of targeted treatments, advanced surgical interventions, the evolution of personalized healthcare, along with improvements in supportive care._x000D_
_x000D_
The market for gastrointestinal stromal tumors is projected to witness robust expansion in the coming years, reaching an estimated value of $1.82 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 7.4%. This expansion during the forecast period can be credited to consistent research and drug development efforts, the surge in patient-focused healthcare, the implementation of precision medicine in clinical routines, enhanced access to specified therapies, and growing genomic profiling capabilities. Notable trends anticipated in the forecast timeframe encompass increasing partnerships in research and development activities, advancements in diagnostic technology, collective scientific research and clinical testings, heightened attention on early detection and diagnosis, and the investigation of combined therapy options._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=13248&type=smp_x000D_
_x000D_
#Which Factors and External Forces Are Driving Demand in the Gastrointestinal Stromal Tumor Market?#_x000D_
The increasing number of stomach cancer cases is expected to push the gastrointestinal stromal tumor market’s growth. Stomach cancer is characterised by the uncontrollable growth and spread of malignant cells in the stomach’s lining. Although gastrointestinal stromal tumors (GISTs) can also occur in the stomach, these are not the same as stomach cancer. Patients with GISTs have been observed to have a higher risk of developing additional cancers, such as small bowel adenocarcinoma, when two distinct tumors collide and become one. For instance, the American Cancer Society predicted approximately 26,890 new stomach cancer cases and 10,880 deaths in the U.S. by January 2024, making up 1.5% of all new cancer diagnoses. This surge in stomach cancer incidence is thereby fuelling the expansion of the gastrointestinal stromal tumor market.
Driving Factors for the Gastrointestinal Stromal Tumor Market: Increasing Demand for Precision Medicine Propels Market Further
_x000D_
_x000D_
#Which Segments in the Gastrointestinal Stromal Tumor Offer the Most Growth?#_x000D_
The gastrointestinal stromal tumor market covered in this report is segmented –_x000D_
_x000D_
1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types_x000D_
2) By Indication: Stomach, Small Intestine, Others Indications_x000D_
3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens_x000D_
2) By Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Agents_x000D_
3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=13248&type=smp_x000D_
_x000D_
#What Are the Fastest-Growing Geographies in the Gastrointestinal Stromal Tumor Market?#_x000D_
North America was the largest region in the gastrointestinal stromal tumor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
#Which Cutting-Edge Market Trends Are Expected to Drive theGastrointestinal Stromal Tumor Market’s Growth?#_x000D_
Leading firms in the gastrointestinal stromal tumor market are pioneering the innovation of new drugs like QINLOCK (Ripretinib) with an aim to reach a wider customer base, boost sales, and augment revenues. QINLOCK (Ripretinib) serves as a prescribed medication used for the treatment of an advanced gastrointestinal stromal tumor (GIST). For example, data from the US Food and Drug Administration (FDA), a federal agency based in the US, reveals that the CDER novel drug approvals rose from 37 in 2022 to 55 in 2023, in January 2024. Further, CDER classified 20 out of the 55 novel drugs (36%) granted approval in 2023 as first-in-class._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#What Are the Key Elements That Define the Gastrointestinal Stromal Tumor Market?#_x000D_
A gastrointestinal stromal tumor (GIST) is a type of rare, non-epithelial tumor that originates in the gastrointestinal (GI) tract. These are most commonly developed in the stomach or the small intestine, but they can occur anywhere along the GI tract, from the esophagus to the rectum._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13248_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
